InvestorsHub Logo
Followers 50
Posts 9063
Boards Moderated 1
Alias Born 01/13/2007

Re: XenaLives post# 7588

Monday, 12/17/2018 7:34:40 PM

Monday, December 17, 2018 7:34:40 PM

Post# of 21540
We probably won't. Fragile X is already slated as a 2a and if all goes safely with those young folks, i expect Rett to follow the same path. NP-C as well. We would be looking at a half dozen 2a trials at some point in the future. Will be interesting to see what they choose to focus on outside alz and fragile x
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SNPX News